A61K 9/0087
Galenical forms not covered by a61k9/02 - a61k9/7023
Official title: {Galenical forms not covered by A61K9/02 - A61K9/7023}
A61K9/0087 (Galenical forms not covered by a61k9/02 - a61k9/7023) appears on 4,097 US grants and 7,188 published applications in this corpus.
Search patents in A61K- Granted patents
- 4,097
- Published applications
- 7,188
- Assignees
- 2,914
- Inventors
- 11,752
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 12 | 0 |
| 1977 | 5 | 0 |
| 1978 | 9 | 0 |
| 1979 | 2 | 0 |
| 1980 | 5 | 0 |
| 1981 | 8 | 0 |
| 1982 | 6 | 0 |
| 1983 | 3 | 0 |
| 1984 | 5 | 0 |
| 1985 | 5 | 0 |
| 1986 | 5 | 0 |
| 1987 | 10 | 0 |
| 1988 | 11 | 0 |
| 1989 | 22 | 0 |
| 1990 | 21 | 0 |
| 1991 | 22 | 0 |
| 1992 | 26 | 0 |
| 1993 | 19 | 0 |
| 1994 | 26 | 0 |
| 1995 | 28 | 0 |
| 1996 | 39 | 0 |
| 1997 | 52 | 0 |
| 1998 | 41 | 0 |
| 1999 | 49 | 0 |
| 2000 | 37 | 0 |
| 2001 | 48 | 12 |
| 2002 | 46 | 95 |
| 2003 | 61 | 131 |
| 2004 | 38 | 155 |
| 2005 | 43 | 156 |
| 2006 | 58 | 171 |
| 2007 | 35 | 183 |
| 2008 | 24 | 182 |
| 2009 | 44 | 177 |
| 2010 | 75 | 219 |
| 2011 | 65 | 215 |
| 2012 | 106 | 214 |
| 2013 | 167 | 258 |
| 2014 | 169 | 313 |
| 2015 | 196 | 298 |
| 2016 | 182 | 407 |
| 2017 | 217 | 407 |
| 2018 | 207 | 358 |
| 2019 | 222 | 379 |
| 2020 | 254 | 476 |
| 2021 | 267 | 510 |
| 2022 | 262 | 476 |
| 2023 | 227 | 419 |
| 2024 | 236 | 392 |
| 2025 | 245 | 324 |
| 2026 | 135 | 261 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Oral and intestinal health products6 Oct 2026US 12,751,985 B2
- Color-changing antibacterial nanofiber29 Sep 2026US 12,746,214 B2University of Manitoba
- Composition and method to reduce liver fat and circulating triacylglycerols22 Sep 2026US 12,740,957 B2
- Methods of treating Lennox-Gastaut Syndrome using fenfluramine15 Sep 2026US 12,734,137 B2Zogenix International Limited
- Pharmaceutical powder compositions including potassium chloride and methods of making and using the same15 Sep 2026US 12,734,192 B1Genus Lifesciences Inc.
- Tea compositions comprising paraxanthine and methods of production thereof8 Oct 2026US 2026/0305643 A1
- Formulation for an effective oral administration of ciclopirox with no adversal gastrointestinal toxicity8 Oct 2026US 2026/0306400 A1AsociacióN Centro De InvestigacióN Cooperativa En Biociencias-Cic Biogune
- Nutritional compositions, supplements, and fortifiers8 Oct 2026US 2026/0306432 A1Societe des Produits Nestle S. A.
- Nicotine Pouch8 Oct 2026US 2026/0306475 A1Philip Morris Products S. A.
- Composition for kidney treatment using omentum, a medical kit for kidney treatment, including the same, and film for kidney treatment, including cured product thereof8 Oct 2026US 2026/0306550 A1Rokit Healthcare Inc.
Most cited
By later US patents
- Renewable neural implant device and method1,456US 5,554,148 ABrown University Research Foundation · 1996
- Drug depot implant designs1,379US 7,727,954 B2Warsaw Orthopedic, Inc. · 2010
- Drug-delivering composite structures814US 9,446,226 B2Ramot at Tel-Aviv University Ltd. · 2016
- Microchip drug delivery devices675US 5,797,898 AMassachusetts Institute of Technology · 1998
- Controlled release powder and process for its preparation660US 5,354,556 AElan Corporation, plc · 1994